234 related articles for article (PubMed ID: 9241735)
1. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
2. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
3. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
5. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
[TBL] [Abstract][Full Text] [Related]
6. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
7. Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis.
Blann AD; Faragher EB; McCollum CN
Blood Coagul Fibrinolysis; 1997 Oct; 8(7):383-90. PubMed ID: 9391718
[TBL] [Abstract][Full Text] [Related]
8. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
9. Production of soluble P-selectin by platelets and endothelial cells.
Semenov AV; Romanov YA; Loktionova SA; Tikhomirov OY; Khachikian MV; Vasil'ev SA; Mazurov AV
Biochemistry (Mosc); 1999 Nov; 64(11):1326-35. PubMed ID: 10611541
[TBL] [Abstract][Full Text] [Related]
10. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Wolf F; Labs KH; Jäger KA; Marbet GA
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):165-73. PubMed ID: 10759010
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
12. Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
Vianelli N; Catani L; Gugliotta L; Nocentini F; Baravelli S; Lancellotti G; Tura S
Haematologica; 1996; 81(1):3-7. PubMed ID: 8900845
[TBL] [Abstract][Full Text] [Related]
13. Systemic endothelial cell markers in primary antiphospholipid syndrome.
Williams FM; Parmar K; Hughes GR; Hunt BJ
Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
Blann AD; Choudhury A; Freestone B; Patel J; Lip GY
Int J Cardiol; 2008 Jun; 127(1):135-7. PubMed ID: 17555832
[TBL] [Abstract][Full Text] [Related]
16. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
[TBL] [Abstract][Full Text] [Related]
17. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
[TBL] [Abstract][Full Text] [Related]
18. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
19. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
20. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
